Ulrich Mansmann
Overview
Explore the profile of Ulrich Mansmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
290
Citations
4397
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Fusiak J, Mansmann U, Hoffmann V
JBI Evid Synth
. 2024 Aug;
22(12):2593-2600.
PMID: 39194046
Objective: The objective of this scoping review is to identify and map methods used to incorporate patient preferences into medical algorithms and models as well as to report on their...
12.
Hoffmann V, Schonecker S, Amin M, Reidler P, Brauer A, Kopczak A, et al.
J Neurol
. 2024 Jul;
271(9):6238-6246.
PMID: 39085620
Background: Juvenile strokes (< 55 years) account for about 15% of all ischemic strokes. Structured data on clinical outcome in those patients are sparse. Here, we aimed to fill this...
13.
Kratzer V, Rolz V, Bidlingmaier C, Klamroth R, Behringer J, Schramm A, et al.
Hamostaseologie
. 2024 Jul;
PMID: 38950623
Claims data are increasingly discussed to evaluate health care for rare diseases (resource consumption, outcomes and costs). Using haemophilia A (HA) as a use case, this analysis aimed to generate...
14.
Sakr A, Mansmann U, Havla J, Irmak On B
BMC Med Res Methodol
. 2024 Jun;
24(1):138.
PMID: 38914938
Background: Individualizing and optimizing treatment of relapsing-remitting multiple sclerosis patients is a challenging problem, which would benefit from a clinically valid decision support. Stühler et al. presented black box models...
15.
Maier S, Schonecker S, Anagnostatou V, Garny S, Nitschmann A, Fleischmann D, et al.
Clin Transl Radiat Oncol
. 2024 May;
47:100790.
PMID: 38765202
Background: The PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06; NCT05871021) is designed to determine whether a dose escalation with 75.0 Gy in 30 fractions can enhance the median overall survival (OS) in...
16.
Grill E, Darrouzet V, Mansmann U, Chabbert C
J Neurol
. 2024 May;
271(8):4865-4870.
PMID: 38727733
Vestibular problems are frequent reasons for primary care consultations. However, there is considerable uncertainty about the prevalence and cost of vestibular disorders. Despite ambiguous effectiveness data, the histamine analogue betahistine...
17.
Weissgerber T, Gazda M, Nilsonne G, Ter Riet G, Cobey K, Priess-Buchheit J, et al.
Nat Med
. 2024 Mar;
30(5):1220-1221.
PMID: 38514869
No abstract available.
18.
Bayas A, Mansmann U, Irmak On B, Hoffmann V, Berthele A, Muhlau M, et al.
Neurol Res Pract
. 2024 Mar;
6(1):15.
PMID: 38449051
Introduction: In Multiple Sclerosis (MS), patients´ characteristics and (bio)markers that reliably predict the individual disease prognosis at disease onset are lacking. Cohort studies allow a close follow-up of MS histories...
19.
Loidl V, Klinc C, Fusiak J, Crispin A, Hoffmann V, Nennstiel-Ratzel U, et al.
Gesundheitswesen
. 2024 Feb;
86(3):237-246.
PMID: 38316408
In the school years 2019/20 and 2020/21, children were physically, psychologically, and socially stressed by school closures caused by the SARS-CoV-2 pandemic. To ensure attendance with optimal infection protection, PCR...
20.
Rehms R, Ellenbach N, Rehfuess E, Burns J, Mansmann U, Hoffmann S
Biom J
. 2024 Jan;
66(1):e2200341.
PMID: 38285407
Infectious disease models can serve as critical tools to predict the development of cases and associated healthcare demand and to determine the set of nonpharmaceutical interventions (NPIs) that is most...